close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

28.06 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Enovis Corporation Common Stock

< Previous 1 2 3 Next >
Enovis Announces Third Quarter 2025 Results
From Enovis Corporation
Via GlobeNewswire
Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences
From Enovis Corporation
Via GlobeNewswire
Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
From Enovis Corporation
Via GlobeNewswire
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Second Quarter 2025 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis Announces First Quarter 2025 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host First Quarter 2025 Results Conference Call on May 8th
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
From Enovis Corporation
Via GlobeNewswire
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to... 
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Fourth Quarter and Full Year 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Planned CEO Succession Process
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
From Enovis Corporation
Via GlobeNewswire
Enovis™ Announces Leadership Change to International Surgical Business
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Third Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
From Enovis Corporation
Via GlobeNewswire
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
From Enovis Corporation
Via GlobeNewswire
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
With the upcoming launch of the innovative Tarsoplasty solution and live demonstrations of the Better Step patient-focused platform, Enovis™ Foot & Ankle continues to drive its portfolio into “The Fast... 
From Enovis Corporation
Via GlobeNewswire
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
First surgeries using EMPOWR Revision Knee™ with EMPOWR™ Cones successfully completed by design consultants Dr. Beau Kildow and Dr. Leonard T. Buller. 
From Enovis Corporation
Via GlobeNewswire
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
Revolutionary Scandinavian Total Ankle Replacement (STAR® Ankle) System Now Includes Vitamin E-Blended Polyethylene Insert 
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Second Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
New full-range solution adds bone-sparing baseplate, peripheral fixation, and glenosphere options to proven reverse shoulder prosthesis (RSP®) glenoid baseplate while maintaining hallmark simplicity... 
From Enovis Corporation
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today